These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30442330)

  • 41. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
    Hu X; Li E; Zhou Y; You Q; Jiang Z
    Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting Cbl-b in cancer immunotherapy.
    Augustin RC; Bao R; Luke JJ
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population.
    Doníz-Padilla L; Martínez-Jiménez V; Niño-Moreno P; Abud-Mendoza C; Hernández-Castro B; González-Amaro R; Layseca-Espinosa E; Baranda-Cándido L
    Lupus; 2011 May; 20(6):628-35. PubMed ID: 21558139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ubiquitin ligase Cbl-b and obesity-induced insulin resistance.
    Abe T; Hirasaka K; Kohno S; Ochi A; Yamagishi N; Ohno A; Teshima-Kondo S; Nikawa T
    Endocr J; 2014; 61(6):529-38. PubMed ID: 24614797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
    St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
    J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of immune system development and function by Cbl-mediated ubiquitination.
    Li X; Gong L; Gu H
    Immunol Rev; 2019 Sep; 291(1):123-133. PubMed ID: 31402498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.
    Xiao Y; Qiao G; Tang J; Tang R; Guo H; Warwar S; Langdon WY; Tao L; Zhang J
    J Immunol; 2015 Nov; 195(9):4218-27. PubMed ID: 26416283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells.
    Krawczyk C; Bachmaier K; Sasaki T; Jones RG; Snapper SB; Bouchard D; Kozieradzki I; Ohashi PS; Alt FW; Penninger JM
    Immunity; 2000 Oct; 13(4):463-73. PubMed ID: 11070165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
    Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
    Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
    Zhang J; Bárdos T; Li D; Gál I; Vermes C; Xu J; Mikecz K; Finnegan A; Lipkowitz S; Glant TT
    J Immunol; 2002 Sep; 169(5):2236-40. PubMed ID: 12193687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia.
    Liu L; Xiang Y; Shao L; Yuan C; Song X; Sun M; Liu Y; Zhang X; Du S; Hou M; Peng J; Shi Y
    J Thromb Haemost; 2024 Apr; 22(4):1202-1214. PubMed ID: 38184203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cbl-b regulates the CD28 dependence of T-cell activation.
    Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
    Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).
    Zhou L; Yang J; Zhang K; Wang T; Jiang S; Zhang X
    J Med Chem; 2024 Jan; 67(2):816-837. PubMed ID: 38181380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity.
    Han S; Liu ZQ; Chung DC; Paul MS; Garcia-Batres CR; Sayad A; Elford AR; Gold MJ; Grimshaw N; Ohashi PS
    Cancer Immunol Res; 2022 Apr; 10(4):437-452. PubMed ID: 35181779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
    Tran CW; Saibil SD; Le Bihan T; Hamilton SR; Lang KS; You H; Lin AE; Garza KM; Elford AR; Tai K; Parsons ME; Wigmore K; Vainberg MG; Penninger JM; Woodgett JR; Mak TW; Ohashi PS
    J Immunol; 2017 Dec; 199(12):4056-4065. PubMed ID: 29109121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells.
    Gruber T; Hinterleitner R; Hermann-Kleiter N; Meisel M; Kleiter I; Wang CM; Viola A; Pfeifhofer-Obermair C; Baier G
    J Mol Cell Biol; 2013 Dec; 5(6):358-68. PubMed ID: 23709694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
    Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
    Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
    Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex.
    Myers MD; Sosinowski T; Dragone LL; White C; Band H; Gu H; Weiss A
    Nat Immunol; 2006 Jan; 7(1):57-66. PubMed ID: 16327786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.